Muscarinic Acetylcholine Receptors for Psychotic Disorders: Bench-side to Clinic

Dates and Times

Start: 4/18/2023 11:00 AM
End: 4/18/2023 12:00 PM

Objectives

1. Understand the history of using functional muscarinic receptor agonists as potential treatments for psychosis and schizophrenia, and their current status in the drug development pipeline

2. Have a working knowledge of the theoretical basis for muscarinic agonists as targeting symptoms of schizophrenia, and the relationship between muscarinicreceptor pathways and dopamine pathways believed to be involved in schizophrenia

3. The presentation will consider the possible impact of moving away from reliance on direct dopamine receptor antagonism, assuming FDA approval, especially regarding differences in the safety profile of direct muscarinic agonists compared to the more familiar side effects associated with current dopamine receptor antagonists

Grand Round Files

Speakers

Location

Stony Brook Medicine
101 Nicolls Road
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.